VARENICLINE TEVA 0.5 mg, film-coated tablet. varenicline teva 1 mg, film-coated tablet 11 tablets
Active ingredients: Varenicline citrate, Varenicline
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet11 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- VARENICLINE TEVA 0,5 mg, comprimé pelliculé. VARENICLINE TEVA 1 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé et comprimé pelliculé
- Route of administration
- orale
- Presentation description
- plaquettes PVC polyéthylène PVDC aluminium de 11 comprimés de 0,5 mg - plaquettes PVC polyéthylène PVDC aluminium de 14 comprimés de 1 mg
- Marketing authorisation holder
- TEVA (PAYS-BAS)
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 10 Mar 2026
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
65838453CIP73029515CIP133400930295151Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VARÉNICLINEcomprimé 0,5 mg | 0,5 mg · un comprimé | FT |
| CITRATE DE VARÉNICLINEcomprimé 0,5 mg | — | SA |
| VARÉNICLINEcomprimé 1 mg | 1 mg · un comprimé | FT |
| CITRATE DE VARÉNICLINEcomprimé 1 mg | — | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.